cryptocurrencies report Top Overview

General Administration of Market Supervision: Efforts should be made to optimize the consumption environment and promote large-scale equipment renewal and trade-in of consumer goods by standards. The party group of General Administration of Market Supervision held an enlarged meeting to convey the spirit of studying the Central Economic Work Conference. The meeting demanded that the construction of a unified national market should be accelerated, fair competition governance should be strengthened, and the economic cycle should be promoted smoothly. Efforts should be made to optimize the consumption environment, promote large-scale equipment renewal and trade-in of consumer goods with standards, and help expand domestic demand. It is necessary to give full play to the supporting role of quality infrastructure and boost scientific and technological innovation and the development of new quality productive forces. Efforts should be made to standardize the market order and promote mutual benefit and win-win for all parties in the platform economy. It is necessary to constantly optimize the ways and means of market supervision, improve the efficiency of supervision, and stabilize market expectations. It is necessary to effectively improve the safety supervision ability of food, medicine, industrial products and special equipment, and timely prevent and resolve major risks. It is necessary to improve the working mechanism for implementing the decision-making and deployment of the CPC Central Committee and strengthen the comprehensive and strict management of the party's political responsibility. It is necessary to do a good job in safe production in the field of market supervision at the end of the year and at the beginning of the year, and stabilize the price and quality of important people's livelihood commodities.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Guangzhou Institute: Make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. With the rapid development of polysilicon industry, the relationship between supply and demand changes rapidly and the price fluctuates greatly due to various factors such as industrial policy, production cycle and technological progress. Due to the lack of objective and continuous price signals, the polysilicon industry has concentrated capacity investment and construction, which is prone to problems such as staged supply and demand mismatch, which is not conducive to the healthy and stable development of the industry. In this context, photovoltaic industry chain enterprises have increasingly strong demands for listed polysilicon futures, pricing with futures tools and managing risks. At the same time, the listed polysilicon futures will help to export the international pricing benchmark, form the "China" price of polysilicon international trade reflecting China's industrial volume, and gradually enhance China's influence in polysilicon international trade pricing. The insiders believe that at present, the industrial silicon varieties in Guangzhou have been running smoothly for nearly two years, and the listing of polysilicon varieties will further improve the variety layout of the crystalline silicon industrial chain for futures services, and provide more accurate futures tools for polysilicon and its downstream photovoltaic industrial chain, which is conducive to further consolidating the global competitive advantage of China's photovoltaic and other industries. The relevant person in charge of the Guangzhou Stock Exchange said that in the next step, under the guidance of the China Securities Regulatory Commission, the Guangzhou Stock Exchange will make solid preparations for the listing of polysilicon futures and options to ensure the smooth launch and steady operation of polysilicon futures and options. (Guangzhou Institute)

South Korean courts issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. On December 13th, local time, Seoul Central District Court issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. (CCTV News)Market News: Director of South Korea's National Police Agency will be arrested.Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.

Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Huabei Pharmaceutical Co., Ltd.: Four kinds of drugs under the company are planned to be selected for national centralized drug procurement. Huabei Pharmaceutical announced that the company and its subsidiary Xiantai Company participated in the tenth batch of national centralized drug procurement, and all four varieties are planned to be selected, including penicillin sodium for injection, piperacillin sodium for injection, ampicillin sodium for injection and sulbactam sodium for injection. The price of the drug to be selected this time has decreased compared with the original sales price. In 2023, the sales income of penicillin sodium for injection was 129 million yuan, accounting for 1.28% of the annual operating income. If the bid is confirmed and the purchase and sale contract is signed, the company will fully guarantee the supply according to the demand of the selected area, and promote the increment of related products in the selected area and the development of the off-standard market.On December 13th, Shaanxi Supervision Bureau of the State Financial Supervision and Administration issued an administrative penalty message showing that Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was fined 60,000 yuan for giving benefits other than the insurance contract. The salesman of Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was warned and fined 10,000 yuan.